drugset / Trial / NCT02328053

Clinical & Visual Outcomes of Collagen Cross Linking for Fungal Keratitis

NCT02328053

Unknown 20 enrolled Aravind Eye Care System
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is a randomised control trial to assess the visual and clinical outcomes of collagen cross linking in fungal keratitis. Fungal keratitis is a major cause of corneal blindness in India and the therapeutic options available are minimal to handle the advanced complications and sequalae caused by the disease.The antimicrobial and tissue remodeling role of corneal cross linking was demonstrated by several studies earlier,we anted to specifically assess the role of corneal cross linking in non resolving fungal keratitis in prevention of perforation and enhancement of healing process.

Timeline

Start
2014-02
Primary completion
2015-07
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Background Natamycin Small molecule Topical
Background Voriconazole Small molecule Topical

Indications